Sign inJoin waitlistJoin the waitlist

Ethan Brill

Internal Medicine Residency · Old Dominion University

Credentials: ·

History

Internal Medicine
Old Dominion University
2026–Present
Eastern Virginia Medical School
2022–2026

Research

Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade…
Oncotarget · 2017 · First of 6 authors · 66 citations
Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP
International Journal of Oncology · 2017 · 30 citations
Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer
Cancer Research · 2020 · 29 citations

JL
Jung-Min Lee
3 papers